Clinical trial
Iressa Versus Docetaxel (Taxotere)
NCT00076388
Study timeline
Study start (unknown)2004-02-01Date precision: month
Registry last updated2011-05-13
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Non-Small-Cell Lung Carcinomaunresolved
Interventions
GefitinibDRUG · verified · RxNorm: gefitinib
DocetaxelDRUG · verified · RxNorm: docetaxel
Sponsors & collaborators
AstraZenecalead sponsor
Mapped research locations
HoustonTexas, United States1Los AngelesCalifornia, United States1PhiladelphiaPennsylvania, United States1DallasTexas, United States1TorontoOntario, Canada1NashvilleTennessee, United States1SeattleWashington, United States1ClevelandOhio, United States1PittsburghPennsylvania, United States1BirminghamAlabama, United States1PortlandOregon, United States1BerlinGermany1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00076388 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.